FDA Import Refusal SCS-7478370-8/11/3 — PUSHTI CARE EXIM
The FDA refused shipment SCS-7478370-8/11/3 from PUSHTI CARE EXIM (India) on May 23, 2023. The refused product falls under Drugs and Biologics — TADALAFIL. Cited charge: 75
Refusal details
- Date
- May 23, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66SCA51 TADALAFIL
- Charges
- 75